Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. AMIX
AMIX logo

AMIX Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Autonomix Medical Inc (AMIX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Sell
Latest Price
6.460
1 Day change
-1.70%
52 Week Range
55.440
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

AMIX is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is trending weakly, no bullish proprietary signal is present, there is no recent news catalyst, and there is no supportive financial or valuation data to justify a long-term entry. Given the user is impatient and does not want to wait for an ideal entry, the clearest decision is to avoid buying now and prefer sell/avoid until trend and fundamentals improve.

Technical Analysis

The technical picture is bearish. Price closed at 5.92 after a sharp drop from 6.43, with both regular-session and post-market weakness. MACD histogram is negative and still below zero, indicating downside momentum remains in place. RSI_6 at 40.5 is neutral but leaning weak, not oversold enough to confidently signal a rebound. Moving averages are bearish with SMA_200 > SMA_20 > SMA_5, which confirms a downtrend across short, medium, and long horizons. Price is sitting near S1 at 5.955, with the next support at 5.367; resistance begins at 6.905 and above. The stock trend model also shows only modest near-term upside probabilities, not enough to offset the current technical weakness.

Positive Catalysts

  • ["No news was reported in the recent week, so there are no immediate event-driven positives.", "Technicals show the stock is near support, which could allow a short-term bounce if buyers step in.", "Projected stock trend model suggests some limited upside probability over the next week and month."]

Neutral/Negative Catalysts

  • ["No recent news catalysts to support the stock.", "Hedge funds are neutral with no significant trading trends over the last quarter.", "Insiders are neutral with no significant trading trends over the last month.", "AI Stock Picker shows no signal today.", "SwingMax shows no signal recently.", "Bearish moving averages and negative MACD indicate continued downward pressure.", "No valuation data and financial snapshot data is unavailable, reducing confidence in a long-term buy case.", "No recent congress trading data available.", "The stock fell sharply on the latest session and remains below key resistance."]

Financial Performance

No usable financial snapshot was available because of a data error, so there is no reliable latest-quarter financial readout to support a long-term buying decision. The latest quarter season cannot be confirmed from the provided data. As a result, revenue, growth, and profitability trends are not assessable here.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so there is no visible recent Wall Street upgrade/downgrade trend. Based on the available data, Wall Street pros appear neutral to cautious: there is no bullish rating momentum, no price target support, no positive news flow, and no confirmed accumulation from insiders or hedge funds.

Wall Street analysts forecast AMIX stock price to fall
1 Analyst Rating
Wall Street analysts forecast AMIX stock price to fall
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 6.570
sliders
Low
5
Averages
5
High
5
Current: 6.570
sliders
Low
5
Averages
5
High
5
Maxim
Maxim
Buy
downgrade
$5 -> $2
AI Analysis
2026-02-17
Reason
Maxim
Maxim
Price Target
$5 -> $2
AI Analysis
2026-02-17
downgrade
Buy
Reason
Maxim lowered the firm's price target on Autonomix to $2 from $5 and keeps a Buy rating on the shares. The company's Q3 results were slightly better than expected, though the firm is cutting its price target on expected share dilution from a likely capital raise, the analyst tells investors in a research note.

People Also Watch